Stanley J. Szefler spends much of his time researching Asthma, Internal medicine, Randomized controlled trial, Anesthesia and Placebo. His studies in Asthma integrate themes in fields like Corticosteroid and Respiratory disease. His research in Internal medicine intersects with topics in Endocrinology and Allergy.
His Randomized controlled trial study combines topics from a wide range of disciplines, such as Regimen, Physical therapy, Clinical trial and Pediatrics. His Anesthesia study incorporates themes from Clinical research and Crossover study. His Placebo research incorporates elements of Adverse effect, Intention-to-treat analysis, Surgery and Intensive care.
His primary scientific interests are in Asthma, Internal medicine, Immunology, Intensive care medicine and Pediatrics. Stanley J. Szefler interconnects Placebo, Anesthesia, Physical therapy and Allergy in the investigation of issues within Asthma. His Anesthesia research is multidisciplinary, relying on both Theophylline, Randomized controlled trial and Bronchodilator.
The Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology. He regularly ties together related areas like Respiratory disease in his Immunology studies. His Intensive care medicine research incorporates themes from Psychological intervention, MEDLINE, Intervention, Adverse effect and Disease.
His main research concerns Asthma, Internal medicine, Intensive care medicine, MEDLINE and Pediatrics. Stanley J. Szefler specializes in Asthma, namely Asthma control. In the subject of general Internal medicine, his work in Eosinophil, Corticosteroid and Exhaled nitric oxide is often linked to In patient, thereby combining diverse domains of study.
His research integrates issues of Randomized controlled trial and Asthma treatment in his study of Exhaled nitric oxide. His research on Intensive care medicine also deals with topics like
The scientist’s investigation covers issues in Asthma, Internal medicine, MEDLINE, Intensive care medicine and Pediatrics. His research in Asthma is mostly focused on Inhaler. Many of his studies on Internal medicine apply to Placebo as well.
As a member of one scientific family, he mostly works in the field of MEDLINE, focusing on Social determinants of health and, on occasion, Psychological intervention. His Intensive care medicine study combines topics in areas such as Pediatric asthma, Quality of life, COPD, Spirometry and Biologic therapies. His work is dedicated to discovering how Pediatrics, Global health are connected with Pneumonia, Interquartile range and Incidence and other disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Long-term effects of budesonide or nedocromil in children with asthma.
Stanley Szefler;Scott Weiss;James Tonascia.
The New England Journal of Medicine (2000)
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.
Helen K. Reddel;D. Robin Taylor;Eric D. Bateman;Louis-Philippe Boulet.
American Journal of Respiratory and Critical Care Medicine (2009)
Long-term inhaled corticosteroids in preschool children at high risk for asthma.
Theresa W. Guilbert;Wayne J. Morgan;Robert S. Zeiger;Robert S. Zeiger;David T. Mauger.
The New England Journal of Medicine (2006)
Proceedings of the ATS Workshop on Refractory Asthma Current Understanding, Recommendations, and Unanswered Questions
Sally E. Wenzel;John V. Fahy;Charles Irvin;Stephen P. Peters.
American Journal of Respiratory and Critical Care Medicine (2000)
Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids.
Sally E. Wenzel;Stanley J. Szefler;Donald Y. M. Leung;Steven I. Sloan.
American Journal of Respiratory and Critical Care Medicine (1997)
A summary of the new GINA strategy: a roadmap to asthma control.
Helen K. Reddel;Eric D. Bateman;Allan Becker;Louis-Philippe Boulet.
European Respiratory Journal (2015)
The Effect of Polymorphisms of the β2-Adrenergic Receptor on the Response to Regular Use of Albuterol in Asthma
Elliot Israel;Jeffrey M. Drazen;Stephen B. Liggett;Homer A. Boushey.
American Journal of Respiratory and Critical Care Medicine (2000)
International consensus on (ICON) pediatric asthma
N. G. Papadopoulos;H. Arakawa;A. Custovic;J. Gern.
Allergy (2012)
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial
Elliot Israel;Vernon M. Chinchilli;Jean G. Ford;Homer A. Boushey.
The Lancet (2004)
Significant variability in response to inhaled corticosteroids for persistent asthma
Stanley J. Szefler;Richard J. Martin;Tonya Sharp King;Homer A. Boushey.
The Journal of Allergy and Clinical Immunology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Jewish Health
Kaiser Permanente
University of Wisconsin–Madison
National Jewish Health
Pennsylvania State University
University of Wisconsin–Madison
Case Western Reserve University
Brigham and Women's Hospital
Washington University in St. Louis
Pennsylvania State University
University of Illinois at Urbana-Champaign
University of Gothenburg
World Bank
Carnegie Mellon University
Technion – Israel Institute of Technology
University of Mississippi
Hong Kong University of Science and Technology
The University of Texas at Austin
Fudan University
University of Missouri
New York University
Centre national de la recherche scientifique, CNRS
Universidade Federal de Ouro Preto
The University of Texas Health Science Center at Houston
Seoul National University Hospital